These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 33292218)

  • 1. DARS-AS1 accelerates the proliferation of cervical cancer cells via miR-628-5p/JAG1 axis to activate Notch pathway.
    Chen Y; Wu Q; Lin J; Wei J
    Cancer Cell Int; 2020 Nov; 20(1):535. PubMed ID: 33292218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long Noncoding RNA
    Xie F; Xie G; Sun Q
    Cancer Biother Radiopharm; 2020 Mar; 35(2):129-136. PubMed ID: 32077747
    [No Abstract]   [Full Text] [Related]  

  • 3. DARS-AS1 promotes clear cell renal cell carcinoma by sequestering miR-194-5p to up-regulate DARS.
    Jiao M; Guo H; Chen Y; Li L; Zhang L
    Biomed Pharmacother; 2020 Aug; 128():110323. PubMed ID: 32526457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long Non-Coding RNA DARS-AS1 Contributes to Prostate Cancer Progression Through Regulating the MicroRNA-628-5p/MTDH Axis.
    Fan H; Hou J; Liu S; Xiao Z; Cui J
    Cancer Manag Res; 2020; 12():8363-8377. PubMed ID: 32982430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DARS-AS1 Knockdown Inhibits the Growth of Cervical Cancer Cells via Downregulating HMGB1 via Sponging miR-188-5p.
    Zhu J; Han S
    Technol Cancer Res Treat; 2020; 19():1533033820971669. PubMed ID: 33176595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA BBOX1-AS1 upregulates HOXC6 expression through miR-361-3p and HuR to drive cervical cancer progression.
    Xu J; Yang B; Wang L; Zhu Y; Zhu X; Xia Z; Zhao Z; Xu L
    Cell Prolif; 2020 Jul; 53(7):e12823. PubMed ID: 32515533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DGUOK-AS1 promotes cell proliferation in cervical cancer via acting as a ceRNA of miR-653-5p.
    Wu N; Song H; Ren Y; Tao S; Li S
    Cell Biochem Funct; 2020 Oct; 38(7):870-879. PubMed ID: 32283566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA LIPE-AS1 Predicts Poor Survival of Cervical Cancer and Promotes Its Proliferation and Migration via Modulating miR-195-5p/MAPK Pathway.
    Zhang J; Jiang P; Wang S; Cheng W; Fu S
    Front Oncol; 2021; 11():639980. PubMed ID: 33898314
    [No Abstract]   [Full Text] [Related]  

  • 9. LncRNA LBX2-AS1 facilitates abdominal aortic aneurysm through miR-4685-5p/LBX2 feedback loop.
    Li H; Zhang H; Wang G; Chen Z; Pan Y
    Biomed Pharmacother; 2020 Sep; 129():109904. PubMed ID: 32559617
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Shen C; Wang B; Zhang K; Wang C; Wang J; An Z; Shu L
    Transl Cancer Res; 2020 May; 9(5):3180-3190. PubMed ID: 35117684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of lncRNA DARS-AS1 accelerates tumor malignancy in cervical cancer by activating cGMP-PKG pathway.
    Kong X; Wang JS; Yang H
    J Biochem Mol Toxicol; 2021 Jun; 35(6):1-11. PubMed ID: 33634536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The LOXL1 antisense RNA 1 (LOXL1-AS1)/microRNA-423-5p (miR-423-5p)/ectodermal-neural cortex 1 (ENC1) axis promotes cervical cancer through the mitogen-activated protein kinase (MEK)/extracellular signal-regulated kinase (ERK) pathway.
    Zhang P; Zhao F; Jia K; Liu X
    Bioengineered; 2022 Feb; 13(2):2567-2584. PubMed ID: 35015607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA DARS-AS1 acts as an oncogene by targeting miR-532-3p in ovarian cancer.
    Huang K; Fan WS; Fu XY; Li YL; Meng YG
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2353-2359. PubMed ID: 30964159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DARS-AS1 recruits METTL3/METTL14 to bind and enhance DARS mRNA m
    Shen W; Zhu M; Wang Q; Zhou X; Wang J; Wang T; Zhang J
    RNA Biol; 2022 Jan; 19(1):751-763. PubMed ID: 35638109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA STXBP5-AS1 suppressed cervical cancer progression via targeting miR-96-5p/PTEN axis.
    Shao S; Wang C; Wang S; Zhang H; Zhang Y
    Biomed Pharmacother; 2019 Sep; 117():109082. PubMed ID: 31212131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel mechanism by which ACTA2-AS1 promotes cervical cancer progression: acting as a ceRNA of miR-143-3p to regulate SMAD3 expression.
    Luo L; Wang M; Li X; Luo C; Tan S; Yin S; Liu L; Zhu X
    Cancer Cell Int; 2020; 20():372. PubMed ID: 32774166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
    Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
    Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GATA1-Activated HNF1A-AS1 Facilitates the Progression of Triple-Negative Breast Cancer via Sponging miR-32-5p to Upregulate RNF38.
    Yang J; Niu H; Chen X
    Cancer Manag Res; 2021; 13():1357-1369. PubMed ID: 33603481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA ASB16-AS1 enhances cell proliferation, migration and invasion via functioning as a ceRNA through miR-1305/Wnt/β-catenin axis in cervical cancer.
    Liu W; Zhuang R; Feng S; Bai X; Jia Z; Kapora E; Tan W
    Biomed Pharmacother; 2020 May; 125():109965. PubMed ID: 32058219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FGD5-AS1 facilitates glioblastoma progression by activation of Wnt/β-catenin signaling via regulating miR-129-5p/HNRNPK axis.
    Wu L; Zhu X; Song Z; Guo M; Liang J; Yan D
    Life Sci; 2020 Sep; 256():117998. PubMed ID: 32585241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.